Gregor Serša

18.1k total citations · 2 hit papers
353 papers, 13.6k citations indexed

About

Gregor Serša is a scholar working on Biotechnology, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Gregor Serša has authored 353 papers receiving a total of 13.6k indexed citations (citations by other indexed papers that have themselves been cited), including 262 papers in Biotechnology, 167 papers in Biomedical Engineering and 106 papers in Molecular Biology. Recurrent topics in Gregor Serša's work include Microbial Inactivation Methods (257 papers), Microfluidic and Bio-sensing Technologies (136 papers) and Toxin Mechanisms and Immunotoxins (74 papers). Gregor Serša is often cited by papers focused on Microbial Inactivation Methods (257 papers), Microfluidic and Bio-sensing Technologies (136 papers) and Toxin Mechanisms and Immunotoxins (74 papers). Gregor Serša collaborates with scholars based in Slovenia, Italy and United Kingdom. Gregor Serša's co-authors include Maja Čemažar, Damijan Miklavčič, Marko Snoj, Z Rudolf, Tomaž Jarm, Simona Kranjc, Lluis M. Mir, Julie Gehl, Tadej Kotnik and Barbara Černič Mali and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Gregor Serša

342 papers receiving 13.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Electroporation-Based Technologies for Medicine: Principles, Applications, and Challenges

2014 641 citations Gregor Serša, Damijan Miklavčič et al. profile →
Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study

2006 628 citations Gregor Serša, Marko Snoj et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gregor Serša Slovenia	58	10.3k	6.8k	3.5k	3.0k	1.2k	353	13.6k
Maja Čemažar Slovenia	54	7.7k 0.7×	5.0k 0.7×	2.8k 0.8×	2.8k 0.9×	1.2k 1.0×	319	10.9k
Lluis M. Mir France	76	13.0k 1.3×	9.3k 1.4×	3.9k 1.1×	4.6k 1.5×	1.3k 1.1×	262	18.4k
Richard Heller United States	52	5.1k 0.5×	3.2k 0.5×	3.0k 0.9×	3.5k 1.2×	3.0k 2.5×	171	10.7k
Marie‐Pierre Rols France	52	6.1k 0.6×	5.0k 0.7×	1.1k 0.3×	2.7k 0.9×	199 0.2×	193	8.8k
Rafael V. Davalos United States	54	6.6k 0.6×	6.5k 0.9×	1.3k 0.4×	988 0.3×	403 0.3×	221	9.7k
Muriel Golzio France	40	2.6k 0.3×	2.4k 0.4×	564 0.2×	2.3k 0.8×	285 0.2×	126	5.4k
K. Dane Wittrup United States	69	2.1k 0.2×	2.1k 0.3×	4.4k 1.3×	10.4k 3.5×	4.0k 3.4×	235	16.8k
Fan Yuan United States	47	839 0.1×	4.3k 0.6×	543 0.2×	5.0k 1.7×	1.5k 1.2×	149	11.4k
Weiwei Gao United States	75	446 0.0×	11.4k 1.7×	3.2k 0.9×	8.2k 2.7×	1.0k 0.8×	215	20.4k
Antonio Villaverde Spain	54	1.7k 0.2×	1.2k 0.2×	1.1k 0.3×	7.6k 2.5×	634 0.5×	348	10.5k

Countries citing papers authored by Gregor Serša

Since Specialization

Citations

This map shows the geographic impact of Gregor Serša's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregor Serša with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregor Serša more than expected).

Fields of papers citing papers by Gregor Serša

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregor Serša. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregor Serša. The network helps show where Gregor Serša may publish in the future.

Co-authorship network of co-authors of Gregor Serša

This figure shows the co-authorship network connecting the top 25 collaborators of Gregor Serša. A scholar is included among the top collaborators of Gregor Serša based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregor Serša. Gregor Serša is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Markelc, Boštjan, et al.. (2025). Partial versus whole tumor-volume irradiation in combination with immunotherapy: Comparable outcomes in immunosuppressed mouse models of oral squamous cell carcinoma. Biomedicine & Pharmacotherapy. 187. 118107–118107.

Strojan, Primož, Tanja Jesenko, Aleš Grošelj, et al.. (2025). Phase I trial of phIL12 plasmid intratumoral gene electrotransfer in patients with basal cell carcinoma in head and neck region. European Journal of Surgical Oncology. 51(5). 109574–109574. 4 indexed citations

Bertino, Giulia, Barbara Silvestri, Paolo Matteucci, et al.. (2024). Electrochemotherapy (ECT) in treatment of mucosal head and neck tumors. An international network for sharing practices on ECT (InspECT) study group report. European Journal of Surgical Oncology. 50(9). 108473–108473. 3 indexed citations

Muir, Tobian, Walter A. Wohlgemuth, Maja Čemažar, et al.. (2024). Current Operating Procedure (COP) for Bleomycin ElectroScleroTherapy (BEST) of low-flow vascular malformations. Radiology and Oncology. 58(4). 469–479. 7 indexed citations

Kranjc, Simona, et al.. (2023). Effect of electrochemotherapy on myogenesis of mouse C2C12 cells in vitro. Bioelectrochemistry. 153. 108487–108487. 3 indexed citations

Kamenšek, Urška, Maja Čemažar, Simona Kranjc, et al.. (2023). What We Learned about the Feasibility of Gene Electrotransfer for Vaccination on a Model of COVID-19 Vaccine. Pharmaceutics. 15(7). 1981–1981. 1 indexed citations

Markelc, Boštjan, et al.. (2023). Effects of Electrochemotherapy on Immunologically Important Modifications in Tumor Cells. Vaccines. 11(5). 925–925. 14 indexed citations

Čemažar, Maja, et al.. (2022). Electrochemotherapy as an Alternative Treatment Option to Pelvic Exenteration for Recurrent Vulvar Cancer of the Perineum Region. Technology in Cancer Research & Treatment. 21. 2213858377–2213858377. 4 indexed citations

Markelc, Boštjan, et al.. (2022). Estimating quantitative physiological and morphological tissue parameters of murine tumor models using hyperspectral imaging and optical profilometry. Journal of Biophotonics. 16(1). e202200181–e202200181. 5 indexed citations

10.

Dermol‐Černe, Janja, Damijan Miklavčič, Simona Kranjc, et al.. (2022). Design, Development, and Testing of a Device for Gene Electrotransfer to Skin Cells In Vivo. Pharmaceutics. 14(9). 1826–1826. 1 indexed citations

11.

Serša, Gregor, et al.. (2021). Gene electrotransfer of proinflammatory chemokines CCL5 and CCL17 as a novel approach of modifying cytokine expression profile in the tumor microenvironment. Bioelectrochemistry. 140. 107795–107795. 7 indexed citations

12.

Bošnjak, Maša, et al.. (2021). PARP inhibitor olaparib has a potential to increase the effectiveness of electrochemotherapy in BRCA1 mutated breast cancer in mice. Bioelectrochemistry. 140. 107832–107832. 5 indexed citations

13.

Strojan, Primož, Aleš Grošelj, Gregor Serša, et al.. (2021). Electrochemotherapy in Mucosal Cancer of the Head and Neck: A Systematic Review. Cancers. 13(6). 1254–1254. 20 indexed citations

14.

Kamenšek, Urška, et al.. (2021). Mutational burden, MHC-I expression and immune infiltration as limiting factors for in situ vaccination by TNFα and IL-12 gene electrotransfer. Bioelectrochemistry. 140. 107831–107831. 13 indexed citations

15.

Campana, L, Barbara Perić, Matteo Mascherini, et al.. (2021). Combination of Pembrolizumab with Electrochemotherapy in Cutaneous Metastases from Melanoma: A Comparative Retrospective Study from the InspECT and Slovenian Cancer Registry. Cancers. 13(17). 4289–4289. 41 indexed citations

16.

Edhemović, Ibrahim, Erik Brecelj, Maja Čemažar, et al.. (2020). Intraoperative electrochemotherapy of colorectal liver metastases: A prospective phase II study. European Journal of Surgical Oncology. 46(9). 1628–1633. 33 indexed citations

17.

Tozon, Nataša, et al.. (2020). Health‐related quality of life in dogs treated with electrochemotherapy and/or interleukin‐12 gene electrotransfer. Veterinary Medicine and Science. 6(3). 290–298. 14 indexed citations

18.

Jarm, Tomaž, Aleš Grošelj, Ibrahim Edhemović, et al.. (2016). Electrochemotherapy – An effective method for treatment of tumors with combination of chemotherapeutic agent and electric field. SHILAP Revista de lepidopterología. 3 indexed citations

19.

Tozon, Nataša, et al.. (2010). Electrochemotherapy is highly effective for the treatment of canine perianal hepatoid adenoma and epithelioma. Acta veterinaria. 60(2-3). 285–302. 7 indexed citations

20.

Kranjc, Simona, et al.. (2003). Effect of electroporation on radiosensitization with cisplatin in two cell lines with different chemo- and radiosensitivity. Radiology and Oncology. 37(2). 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact